IQE completes £81m share placing, diluting holders by 25%
IQE (AIM:IQE) completed an £81m fundraising through the issue of 332.18m new shares, bringing its total issued share capital to 1.31bn shares. The raise represents a dilution of 25.3% for existing holders, with the Fundraising Shares priced to reflect that scale. The stock fell 6.11% to 47.6p on the day, a reaction consistent with the dilutive weight of the placing.
IQE guides for more than 20% revenue growth in 2026
Alongside the capital raise, IQE set out a materially upgraded financial outlook, guiding for FY 2026 revenue growth in excess of 20% year-on-year. Adjusted EBITDA is expected to reach a high-single digit to low-double digit range, signalling a meaningful step toward profitability. The guidance provides the strategic rationale for the fundraising, positioning the compound semiconductor wafer specialist to fund the capacity and operational investment needed to capture that growth.
Vesuvius holds full-year guidance after steady start
Vesuvius (LSE:VSVS) maintained its full-year guidance after reporting that revenue and trading profit came in slightly ahead of the prior year on a constant-currency basis in the first part of 2026. The molten-metal flow engineering group said it anticipates the second half will be stronger than the first, a sequencing that underpins its unchanged outlook. The stock eased 3.86% to 453.4p, with the market appearing to price in some caution around the currency headwinds implicit in the constant-currency framing.
Defence Holdings strikes equity and revenue deal with OM Defence
Defence Holdings (LSE:VSVS) announced a strategic partnership with OM Defence (LSE:LSE:VSVS) Systems encompassing a revenue participation arrangement and an equity-linked position. The London-listed firm described the agreement as the first commercial validation of its platform, a significant milestone for a business still establishing its operating track record. The deal combines near-term revenue participation with a longer-term equity stake, structuring OM Defence as both a commercial partner and a balance-sheet asset.
Cambridge Cognition partners with Oura on large-scale brain health study
Cambridge Cognition Holdings (AIM:COG) launched an IRB-approved, large-scale remote study in partnership with wearable technology firm Oura, integrating its digital cognitive assessments with continuous biometric data captured by the Oura Ring. The study represents a meaningful expansion of Cambridge Cognition (LSE:COG)'s research footprint into the consumer wearables space, combining clinical-grade cognitive testing with real-world, longitudinal sensor data. The announcement lifted the shares 7.94% to 36.7p.
